Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 5, 1997

View Archived Issues

MRI image-enhancing agents claimed by Nycomed Imaging

HMR describes new cognition-enhancing agents

NES-1 polypeptides reported for carcinoma detection and treatment

Analogues of botulinum toxin discovered with longer half-life

Bone morphogenic protein-10 claimed by Human Genome Sciences

Pineal gland-specific gene-1 disclosed by HGS

Takeda discloses novel cephems

Merck & Co. pursues alpha1a-adrenoceptor antagonists for BPH

PDE IV/TNF production inhibitors claimed by Pfizer

Tanabe synthesizes ET antagonists

Company Profile: NicOx S.A.

IL-6 antagonists from Daicel

AMDL launches new line of diagnostics

Pierre Fabre antidepressant approved in France

Nortran completes trials in volunteers with antiarrhythmic

Myriad strengthens proprietary position for diagnostic for salt-dependent hypertension

Hyal's Solarase submitted for approval

New use of ciclosporin recommended for approval

ChiRex and Cell Therapeutics sign supply agreement

SmithKline Beecham Lyme disease vaccine update

CF gene therapy product enters phase II

American Biogenetic Sciences seeks FDA approval for diagnostic test

FDA panel to review Carticel service

COR Therapeutics' cardiovascular drug candidate enters phase I trials

Impotence Rx expected to enter phase II this year

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...